EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Soluble ST2 Is a Biomarker Associated With Left Ventricular Hypertrophy and Concentric Hypertrophy in Patients With Essential Hypertension

Xia Wang, Shu-Jie Han, Xiao-Li Wang, Yun-Feng Xu, Hui-Cheng Wang, Jiang-Yang Peng, Guang-Ming Pan, Ya-Hui Chen, Chuangchang Wang iD

American Journal of Hypertension · 2024

DOI: 10.1093/ajh/hpae105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hypertension, 2024. Verfasst von Xia Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. Hauptthemen laut MEDLINE: Biomarkers, Essential Hypertension, Hypertrophy, Left Ventricular, Interleukin-1 Receptor-Like 1 Protein. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangzhou Municipal Science and Technology Project, University Joint Funding Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Elevated soluble stimulating factor 2 (sST2) level is observed in cardiovascular diseases, such as heart failure and acute coronary syndrome, which reflects myocardial fibrosis and hypertrophy, indicating adverse clinical outcomes. However, the association between sST2 and hypertensive heart disease are less understood. This study aimed to determine the relationship of sST2 with left ventricular hypertrophy (LVH) and geometric remodeling in essential hypertension (EH). METHODS We enrolled 483 patients (aged 18–80 years; 51.35% female). sST2 measurements and echocardiographic analyses were performed. RESULTS Stepwise multiple linear regression analysis showed significant associations among sST2, left ventricular (LV) mass, and LV mass index. The prevalence of LVH and concentric hypertrophy (CH) increased with higher sST2 grade levels (P for trend < 0.05). Logistic regression analysis suggested that the highest tertile of sST2 was significantly associated with increased LVH risk, compared with the lowest tertile (multivariate-adjusted odds ratio [OR] of highest group: 6.61; P < 0.001). Similar results were observed in the left ventricular geometric remodeling; the highest tertile of sST2 was significantly associated with increased CH risk (multivariate-adjusted OR of highest group: 5.80; P < 0.001). The receiver operating characteristic analysis results revealed that sST2 had potential predictive value for LVH (area under the curve [AUC]: 0.752, 95% confidence interval [CI]: 0.704–0.800) and CH (AUC: 0.750, 95% CI: 0.699–0.802) in patients with EH. CONCLUSIONS High sST2 level is strongly related to LVH and CH in patients with EH and can be used as a biomarker for the diagnosis and risk assessment of hypertensive heart disease. CLINICAL TRIALS REGISTRATION Trial Number ChiCTR2400082764

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersEssential HypertensionHypertrophy, Left VentricularInterleukin-1 Receptor-Like 1 ProteinVentricular RemodelingAdolescentAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedYoung AdultCross-Sectional StudiesEchocardiographyPredictive Value of TestsPrevalenceRisk FactorsVentricular Function, LeftRetrospective Studies

Stichwörter der Autor:innen

concentric hypertrophyessential hypertensionleft ventricular hypertrophysST2

Substanzen

BiomarkersIL1RL1 protein, humanInterleukin-1 Receptor-Like 1 Protein

Autor:innen und Institutionen

  • Department of Cardiovascular, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China.

ORCID-Profile: Chuangchang Wang

Förderung

  • Guangzhou Municipal Science and Technology Project
  • University Joint Funding Project

Zitieren

APA

Wang, X., Han, S. J., Wang, X. L., Xu, Y. F., Wang, H. C., Peng, J. Y., Pan, G. M., Chen, Y. H., & Wang, C. (2024). Soluble ST2 Is a Biomarker Associated With Left Ventricular Hypertrophy and Concentric Hypertrophy in Patients With Essential Hypertension. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpae105

Vancouver

Wang X, Han SJ, Wang XL, Xu YF, Wang HC, Peng JY, et al. Soluble ST2 Is a Biomarker Associated With Left Ventricular Hypertrophy and Concentric Hypertrophy in Patients With Essential Hypertension. American Journal of Hypertension. 2024. doi:10.1093/ajh/hpae105

BibTeX
@article{Wang2024,
  author = {Wang, Xia and Han, Shu-Jie and Wang, Xiao-Li and Xu, Yun-Feng and Wang, Hui-Cheng and Peng, Jiang-Yang and Pan, Guang-Ming and Chen, Ya-Hui and Wang, Chuangchang},
  title = {Soluble ST2 Is a Biomarker Associated With Left Ventricular Hypertrophy and Concentric Hypertrophy in Patients With Essential Hypertension},
  journal = {American Journal of Hypertension},
  year = {2024},
  doi = {10.1093/ajh/hpae105}
}
Kostenlos starten →